| accom | accommodation |
|---|---|
| NPA | National Pharmaceutical Association; National Pituitary Agency; near point accommodation; Nurse Prac... |
| PP | diphosphate group; emphysema [pink puffers]; near point of accommodation [Lat. punctum proximum]; pa... |
| pp | near point of accommodation [Lat. punctum proximum]; postprandial; postpartum |
| pr | far point of accommodation [Lat. punctum remotum]; pair; per rectum; prism |
one and one-half syndrome
| mental disorders diagnosed in childhood | Those psychiatric disorders usually first diagnosed in infancy, childhood, or adolescence. These disorders can also be first diagnosed during other life stages. (12 Dec 1998) |
|---|---|
| child behaviour disorders | Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns. (12 Dec 1998) |
| child development disorders, pervasive | Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements. (12 Dec 1998) |
| child nutrition disorders | Malnutrition, occurring in children ages 2 to 12 years, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected. (12 Dec 1998) |
| child reactive disorders | Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns. (12 Dec 1998) |
| peroxisomal disorders | A heterogeneous group of inherited metabolic disorders in which peroxisomes are either defective or totally lacking and/or there is a dysfunction of single or multiple peroxisomal enzymes. Patients show metabolic defects in all the major biosynthetic peroxisomal pathways, especially failure to synthesise ether lipids, or to oxidise long-chain fatty acids, and accumulate bile acid precursors. The disorders include zellweger syndrome, infantile refsum disease, rhizomelic chondrodysplasia (chondrodysplasia punctata, rhizomelic), and hyperpipecolic acidemia. (12 Dec 1998) |
| personality disorders | A major deviation from normal patterns of behaviour. (12 Dec 1998) |
| growth disorders | Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. The concept includes both acceleration and retardation of growth. (12 Dec 1998) |
| phagocytic dysfunction disorders immunodeficiency | Suppression in number or function of phagocytic cells such as in chronic granulomatous disease. Synonym: phagocytic dysfunction disorders immunodeficiency. Origin: L. Phagedaena, Gr Phago, To eat. (05 Mar 2000) |
| ciliary motility disorders | Disorders characterised by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as kartagener triad (kartagener's syndrome), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis. (12 Dec 1998) |
| phobic disorders | Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable. (12 Dec 1998) |
| civil disorders | Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change. (12 Dec 1998) |
| phosphorus metabolism disorders | Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization. (12 Dec 1998) |
| photosensitivity disorders | Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy. (12 Dec 1998) |
| mood disorders | Those disorders that have a disturbance in mood as their predominant feature. (12 Dec 1998) |